Table of Contents Author Guidelines Submit a Manuscript
International Journal of Dentistry
Volume 2010, Article ID 291072, 4 pages
http://dx.doi.org/10.1155/2010/291072
Case Report

Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report

1Infectious Diseases Clinic, Chulalongkorn University Dental Hospital, Chulalongkorn University, Bangkok 10330, Thailand
2Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, 34 Henri Dunant Road, Pathumwan District, Bangkok 10330, Thailand
3Division of Infectious Diseases, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

Received 25 March 2010; Revised 24 May 2010; Accepted 7 June 2010

Academic Editor: Jasim M. Albandar

Copyright © 2010 Pratanporn Arirachakaran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Al-Hashimi, M. Schifter, and M. Schifter, “Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 103, pp. S25–S31, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. B. Autran, G. Carcelain, and G. Carcelain, “Positive effects of combined antiretroviral therapy on CD4+T cell homeostasis and function in advanced HIV disease,” Science, vol. 277, no. 5322, pp. 112–116, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Cohen, “Thailand's do-it-yourself therapy,” Science, vol. 301, no. 5640, p. 1662, 2003. View at Google Scholar · View at Scopus
  4. M. A. Fischl, D. D. Richman, and D. D. Richman, “The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection,” Annals of Internal Medicine, vol. 112, no. 10, pp. 727–737, 1990. View at Google Scholar · View at Scopus
  5. P. J. Bayard, T. G. Berger, and M. A. Jacobson, “Drug hypersensitivity reactions and human immunodeficiency virus disease,” Journal of Acquired Immune Deficiency Syndromes, vol. 5, no. 12, pp. 1237–1257, 1992. View at Google Scholar · View at Scopus
  6. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents -Department of Health and Human Services.—A Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. January 29, p.1–128, 2008.
  7. C. Scully and P. D. Dios, “Orofacial effects of antiretroviral therapies,” Oral Diseases, vol. 7, no. 4, pp. 205–210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ficarra, C. M. Flaitz, D. Gaglioti, S. Piluso, D. Milo, K. Adler-Storthz, and L. R. Eversole, “White lichenoid lesions of the buccal mucosa in patients with HIV infection,” Oral Surgery Oral Medicine and Oral Pathology, vol. 76, no. 4, pp. 460–466, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Thongprasom, L. Luangjarmekorn, T. Sererat, and W. Taweesap, “Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 21, no. 10, pp. 456–458, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Shiohara and Y. Mizukawa, “The immunological basis of lichenoid tissue reaction,” Autoimmunity Reviews, vol. 4, no. 4, pp. 236–241, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. P. Klanrit, K. Thongprasom, S. Rojanawatsirivej, A. Theamboonlers, and Y. Poovorawan, “Hepatitis C virus infection in Thai patients with oral lichen planus,” Oral Diseases, vol. 9, no. 6, pp. 292–297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A.-Y. Lee and S. Y. Jung, “Two patients with isoniazid-induced photosensitive lichenoid eruptions confirmed by photopatch test,” Photodermatology Photoimmunology and Photomedicine, vol. 14, no. 2, pp. 77–78, 1998. View at Google Scholar · View at Scopus
  13. J. V. Bagán, K. Thongprasom, and C. Scully, “Adverse oral reactions associated with the COX-2 inhibitor rofecoxib,” Oral Diseases, vol. 10, no. 6, pp. 401–403, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. I. Kiki, M. Atasoy, N. Gursan, M. Gundogdu, F. Erdem, and S. Ozdemir, “Lichenoid drug eruption associated with imatinib mesylate: two cases,” European Journal of General Medicine, vol. 4, no. 1, pp. 50–53, 2007. View at Google Scholar · View at Scopus
  15. R. Fernández-Torres, M. Almagro, J. del Pozo, O. Robles, C. Martínez-González, M. Mazaira, and E. Fonseca, “Lichenoid drug eruption induced by olanzapine,” Actas Dermo-Sifiliograficas, vol. 99, no. 3, pp. 221–224, 2008. View at Publisher · View at Google Scholar · View at Scopus